Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment-Reference-Cited by-同舟云学术

Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment

Published:2013-03 Issue:2 Volume:7 Page:102-107
ISSN:1932-0620
Container-title:Journal of Addiction Medicine
language:en
Short-container-title:

Author:

Tetrault Jeanette M.,Kozal Michael J.,Chiarella Jennifer,Sullivan Lynn E.,Dinh An T.,Fiellin David A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference20 articles.

1. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients.;Fisher;JAIDS,2006

2. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Meta-Analysis Review.;Gowing;Cochrane Database Syst Rev,2011

3. HIV drug resistance and HIV transmission risk behaviors among active injection drug users.;Kozal;JAIDS,2005

4. A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care.;Kozal;MedGenMed,2006

5. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care.;Kozal;AIDS,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment;Drug and Alcohol Dependence;2021-02

2. Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs;Journal of Substance Abuse Treatment;2020-04

3. Integration of care for HIV and opioid use disorder;AIDS;2019-04-01

4. “No more falling through the cracks”: A qualitative study to inform measurement of integration of care of HIV and opioid use disorder;Journal of Substance Abuse Treatment;2019-02

5. Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions;Pharmaceutical Research;2015-05-14